Review of EU clinical trials framework on track; directive to be replaced with regulation
This article was originally published in SRA
Executive Summary
The European Commission wants to replace the EU directive on clinical trials – which is currently undergoing revision – with a regulation so as to ensure greater uniformity among member states in implementing the revised provisions, EU commissioner for health and consumer policy John Dalli announced at a 7 March meeting1.
You may also be interested in...
India Proposes Tiered Approach To Oversee Genome Editing
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
UK's MHRA Looks Beyond Brexit Transition Period
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.
UK MHRA Looks Beyond Brexit Transition
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: